About Megan Heaps

Articles by Megan Heaps

How Inflammation Impacts MPN Patients and What You Can Do About It
May 08, 2025
Adding Ibrutinib to Enhance Liso-cel’s Effect Against CLL
May 07, 2025
Understanding and Managing Brain-Related Side Effects of Blood Cancer Treatments
May 05, 2025
Moving Pirtobrutinib to a First-Time Treatment for CLL/SLL?
Apr 30, 2025
Is Odronextamab Effective if CAR-T Stops Working for DLBCL?
Apr 28, 2025
Can CLL Treatment Time Be Shortened with MRD Testing?
Apr 28, 2025
Navigating “Not Looking Sick” While Living With Chronic Blood Cancer
Apr 17, 2025
$Promising Outcomes of Two-Year Pirtobrutinib with Venetoclax for Relapsed/Refractory CLL image$

Promising Outcomes of Two-Year Pirtobrutinib with Venetoclax for Relapsed/Refractory CLL
Apr 08, 2025
Updates on NeoVax, a Vaccine for CLL
Apr 04, 2025
You're Invited: Tampa Myeloma Roundtable – A Must-Attend Event for Patients and Caregivers
Apr 04, 2025
Does Fructose Support Cancer Cells?
Apr 01, 2025
FDA Warns About Risk-Benefit Balance of Duvelisib for CLL
Apr 01, 2025
Loncastuximab for High-Risk R/R Follicular Lymphoma
Mar 28, 2025
Make an Impact with the HealthTree Challenge: Hike and Wellness Event!
Mar 24, 2025
Real World Outcomes of Liso-cel for Large B-cell Lymphoma
Mar 17, 2025
Valarie Traynham’s Advocacy Efforts for Black Myeloma Health
Mar 17, 2025
How Effective is Mosunetuzumab as a First-Time Follicular Lymphoma Treatment?
Mar 17, 2025
Curing CLL? Long-Term CD19 CAR T-Cell Therapy Updates
Mar 12, 2025
Mosunetuzumab + Polatuzumab Promising Trial Results for R/R LBCL
Mar 06, 2025
Is Fedratinib Safe for Myelofibrosis Patients with Low Platelets?
Mar 05, 2025
Which is Better, Starting Rituximab Early or Watch-and-Wait for Low-Burden Follicular Lymphoma?
Mar 04, 2025
Investigating CK0804 as an Add-On Therapy to Ruxolitinib for Improved Myelofibrosis Management
Mar 03, 2025
How Effective is Tab-cel for EBV+ Post-Transplant Lymphoma?
Mar 03, 2025
Biosimilar FDA-Approved for Myeloma Bone Strengthener Denosumab
Feb 28, 2025